Navigation Links
Study points out inequalities in prescribing blood pressure meds
Date:2/18/2014

Primary care doctors are not quick to prescribe antihypertensive medication to young people even after an average of 20 months of high blood pressure. Young adults who are white, male, not on Medicaid and not frequent clinic visitors are especially less likely to receive medication. These are the results of a study by a research team at the University of Wisconsin School of Medicine and Public Health in the United States led by Heather Johnson. It appears in the Journal of General Internal Medicine, published by Springer.

One in every 10 Americans between the ages of 18 and 39 years old suffers from hypertension. Previous research has shown that young adults with hypertension are less likely to receive blood pressure medication than middle-aged and older adults because of lack of healthcare access. Because hypertension in young adulthood increases the risk of future cardiovascular events, medical treatment is advised if a patient's blood pressure isn't lowered through lifestyle modifications. Previous studies have also shown that medication can help control hypertension among young adults better and faster than is the case for older adults.

Johnson's team set about comparing rates and predictors of when young, middle-aged and older adults who make regular primary care visits are put onto antihypertensive medication. They analyzed the records of more than 10,000 adults older than 18 years who visited a large, Midwestern practice from 2008 to 2011.

They found that doctors were 44 percent slower in starting young adults (between the ages of 18 and 39 years old) on hypertension medication than they were for people aged 60 years and older. Males had a 36 percent slower rate of first receiving antihypertensive medication than women, while white patients were also less likely to receive such treatment. The research team believes the latter may be the case because of primary care providers who are responding to the known increased risk of comorbidities with hypertension among minorities, especially African-Americans. Patients with diabetes across all ages were started on relevant treatment 56 percent faster than others.

Johnson calls on guideline-based treatment for all ethnic groups and genders, and for the need to improve hypertension control in young adults. Such interventions should address both bio-behavioral risk factors for hypertension (such as body mass index, exercise and tobacco use) and, when indicated, the initiation of antihypertensive medication.

"Even with regular primary care contact and continued elevated blood pressure, young adults had slower rates of antihypertensive medication initiation than middle-aged and older adults," said Johnson. "In the young adult group, males, patients with mild hypertension, and white patients had a slower rate of medication initiation, while young adults with Medicaid and more clinic visits had faster rates. Lifestyle modification is the cornerstone of hypertension treatment. Young adults need focused blood pressure visits to monitor lifestyle changes and when necessary, intensify treatment."


'/>"/>
Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Related medicine news :

1. Blood test serves as crystal ball for heart transplant patients, UCLA-led study finds
2. Study uncovers surprising differences in brain activity of alcohol-dependent women
3. Tinnitus study signals advance in understanding link between loud sounds exposure and hearing loss
4. Pregnancy study leads to fewer high birth weight babies
5. Metal implants may cut chemotherapy side effects, study suggests
6. New study explains how dense breast tissue drives the early stages of cancer
7. New UK study shows potential for targeting aggressive breast cancers
8. UNC study reveals potential route to bladder cancer diagnostics, treatments
9. Dartmouth study provides first global evidence that foreign aid boosts public opinion
10. Study: Resilience in parents of children undergoing stem cell transplant
11. Grant supports Cedars-Sinai study of possible links between air pollution and brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... and Video Remote Interpreting (VRI) within Healthcare, recently partnered with Heart City ... interpreting (VRI). , For nearly 23 years, Heart City Health Center has provided ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy Group ... associations of medical professionals throughout the country. The Guard was specifically designed to ... and procedures, employee training, regulatory updates, and compliance coaching. , In addition to ...
(Date:2/10/2016)... ... 2016 , ... Emergency rooms provide emergency care to stabilize critical health issues, ... with dental emergencies at risk of losing a tooth or their smiles. Dr. Marine ... Common dental emergencies include:, , Avulsed or knocked-out teeth , ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. Peyman ... is now offering a variety of comprehensive procedures for facial enhancement. The treatments ... volume restoration, lip enhancement and nasal reshaping. , As a result, patients ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of traumatic ... to conduct a survey that takes a closer look at cases of TBI being ... and causes of TBI among the aging population, and identifies the challenges associated with ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... REDWOOD CITY, Calif., Feb. 10, 2016   Genomic Health, Inc. ... progress for the quarter and year ended December 31, 2015. ... in the fourth quarter of 2015, compared with $69.1 million in ... a constant currency basis, revenue increased 9 percent compared with the ... --> U.S. revenue was $63.9 million in the fourth ...
(Date:2/10/2016)... --> --> This press release is intended for U.S. and EU ... .  --> A separate press release has been prepared for use in ... continues to strengthen its presence in Japan ... strengthen its presence in Japan   ... strengthen its presence in Japan   ...
(Date:2/10/2016)... DIEGO , Feb. 10, 2016 ... gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical company ... other chronic diseases, have entered into a Manufacturing Services ... cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in Renova,s ... --> This relationship will leverage Lonza,s expertise ...
Breaking Medicine Technology: